| Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Post-Transplant Lymphoproliferative Disorder (NCT00064246) | National Cancer Institute (NCI) | 2003-07-01 |
| A Dose Finding Phase I Trial of the Combination of Topotecan and PS-341, a Novel Proteasome Inhibitor, in Advanced Malignancies (NCT00068484) | National Cancer Institute (NCI) | 2003-07-01 |
| Gene Therapy in Preventing Cancer in Patients With Premalignant Carcinoma of the Oral Cavity or Pharynx (NCT00064103) | National Cancer Institute (NCI) | 2003-06-01 |
| Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy (NCT00066599) | National Cancer Institute (NCI) | 2003-06-01 |
| Irofulven in Treating Patients With Recurrent or Persistent Ovarian Epithelial or Primary Peritoneal Cancer (NCT00053365) | National Cancer Institute (NCI) | 2003-06-01 |
| Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia (NCT00061945) | National Cancer Institute (NCI) | 2003-06-01 |
| Arsenic Trioxide in Treating Patients With Advanced Cancer of the Esophagus or Gastroesophageal Junction (NCT00061958) | National Cancer Institute (NCI) | 2003-06-01 |
| A Phase I/II Study of Oblimersen Plus Cisplatin and Fluorouracil in Gastric & Esophageal Junction Cancer (NCT00064259) | National Cancer Institute (NCI) | 2003-06-01 |
| Perifosine in Treating Patients With Advanced Soft Tissue Sarcoma (NCT00064324) | National Cancer Institute (NCI) | 2003-06-01 |
| A Phase I, Pharmacological, and Biological Study of OSI-774 in Combination With FOLFOX 4 (5-FU, Leucovorin, and Oxaliplatin) and Bevacizumab (Avastin) in Patients With Advanced Colorectal Cancer (NCT00060411) | National Cancer Institute (NCI) | 2003-06-01 |
| Irinotecan and Cisplatin in Treating Patients Who Are Undergoing Surgery For Locally Advanced Cancer of the Stomach or Gastroesophageal Junction (NCT00062374) | National Cancer Institute (NCI) | 2003-06-01 |
| FR901228 in Treating Patients With Relapsed or Refractory Multiple Myeloma (NCT00066638) | National Cancer Institute (NCI) | 2003-06-01 |
| A Phase II Study of Isolated Hepatic Perfusion (IHP) in Patients With Ocular Melanoma (NCT00062933) | National Cancer Institute (NCI) | 2003-06-01 |
| Pioglitazone Hydrochloride in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia (NCT00099021) | National Cancer Institute (NCI) | 2003-06-01 |
| Establishing an Inflammatory Breast Cancer Registry (NCT00340158) | National Cancer Institute (NCI) | 2003-06-01 |
| Using Fiducial Markers to Aid in Prostate Cancer Radiation Treatment (NCT00061347) | National Cancer Institute (NCI) | 2003-05-23 |
| Sequential Vaccinations in Prostate Cancer Patients (NCT00060528) | National Cancer Institute (NCI) | 2003-05-22 |
| Ipilimumab and Sargramostim in Treating Patients With Metastatic Prostate Cancer (NCT00064129) | National Cancer Institute (NCI) | 2003-05-13 |
| Romidepsin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia (NCT00062075) | National Cancer Institute (NCI) | 2003-05-01 |
| Oblimersen in Treating Patients With Relapsed or Refractory Waldenstrom's Macroglobulinemia (NCT00062244) | National Cancer Institute (NCI) | 2003-05-01 |
| Perifosine in Treating Patients With Recurrent or Metastatic Head and Neck Cancer (NCT00062387) | National Cancer Institute (NCI) | 2003-05-01 |
| Erlotinib, Gemcitabine, and Radiation Therapy in Treating Patients With Locally Advanced Unresectable Pancreatic Cancer (NCT00063947) | National Cancer Institute (NCI) | 2003-05-01 |
| Campath-1H for Treating Adult T-Cell Leukemia/Lymphoma (NCT00061048) | National Cancer Institute (NCI) | 2003-05-01 |
| Oblimersen Plus Doxorubicin and Docetaxel in Treating Patients With Metastatic or Locally Advanced Breast Cancer (NCT00063934) | National Cancer Institute (NCI) | 2003-05-01 |
| Celecoxib in Preventing Cancer in Patients With Rectal Polyps or Colorectal Neoplasia (NCT00043043) | National Cancer Institute (NCI) | 2003-05-01 |
| Fenretinide in Treating Children With Recurrent or Resistant Neuroblastoma (NCT00053326) | National Cancer Institute (NCI) | 2003-05-01 |
| Markers for Early Detection of Prostate Cancer (NCT00340717) | National Cancer Institute (NCI) | 2003-05-01 |
| Erlotinib in Treating Patients With Locally Advanced or Metastatic Papillary Renal Cell Cancer (NCT00060307) | National Cancer Institute (NCI) | 2003-05-01 |
| Tipifarnib in Treating Patients With Metastatic Malignant Melanoma (NCT00060125) | National Cancer Institute (NCI) | 2003-05-01 |
| Imatinib Mesylate in Treating Patients With Recurrent Small Cell Lung Cancer (NCT00052949) | National Cancer Institute (NCI) | 2003-05-01 |
| Halofuginone Hydrobromide in Treating Patients With HIV-Related Kaposi's Sarcoma (NCT00064142) | National Cancer Institute (NCI) | 2003-05-01 |
| Natural History and Management of Pancreatic Lesions in Von Hippel-Lindau Disease (NCT00062166) | National Cancer Institute (NCI) | 2003-04-11 |
| Studying Normal Breast Tissue and Cancer Risk (NCT00341692) | National Cancer Institute (NCI) | 2003-04-07 |
| Cancer Risk in Carriers of the Gene for Xeroderma Pigmentosum (NCT00046189) | National Cancer Institute (NCI) | 2003-04-07 |
| Peptide Vaccination for Patients at High Risk for Recurrent Melanoma (NCT00059475) | National Cancer Institute (NCI) | 2003-04-01 |
| Erlotinib Plus Carboplatin and Paclitaxel in Ovarian Carcinoma (NCT00059787) | National Cancer Institute (NCI) | 2003-04-01 |
| Bortezomib With or Without Irinotecan in Treating Patients With Cancer of the Gastroesophageal Junction or Stomach (NCT00061932) | National Cancer Institute (NCI) | 2003-04-01 |
| Celecoxib in Treating Postmenopausal Women Who Are Undergoing Surgery for Invasive Breast Cancer (NCT00070057) | National Cancer Institute (NCI) | 2003-04-01 |
| Anidulafungin Versus Fluconazole in the Treatment of Candidemia (NCT00058682) | National Cancer Institute (NCI) | 2003-04-01 |
| Flavopiridol in Treating Patients With Previously Treated Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma (NCT00058240) | National Cancer Institute (NCI) | 2003-04-01 |
| Irinotecan and Thalidomide in Treating Patients With Advanced Solid Tumors (NCT00062127) | National Cancer Institute (NCI) | 2003-04-01 |
| Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and Neck (NCT00063895) | National Cancer Institute (NCI) | 2003-04-01 |
| Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer (NCT00060372) | National Cancer Institute (NCI) | 2003-04-01 |
| Alvocidib, Fludarabine Phosphate, and Rituximab in Treating Patients With Lymphoproliferative Disorders or Mantle Cell Lymphoma (NCT00058227) | National Cancer Institute (NCI) | 2003-04-01 |
| Carboplatin and Etoposide With or Without Oblimersen Sodium in Treating Patients With Extensive Stage Small Cell Lung Cancer (NCT00042978) | National Cancer Institute (NCI) | 2003-04-01 |
| Stomach and Esophageal Cancers in Northern Iran (NCT00339742) | National Cancer Institute (NCI) | 2003-03-25 |
| Follow-up of Breast Cancer and Multiple Myeloma Patients Previously Enrolled in NIH Gene Therapy Studies (NCT00427726) | National Cancer Institute (NCI) | 2003-03-06 |
| A Phase II Trial of COL-3 in Patients With HIV Related Kaposi's Sarcoma (NCT00020683) | National Cancer Institute (NCI) | 2003-03-01 |
| Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer (NCT00055913) | National Cancer Institute (NCI) | 2003-03-01 |
| Ixabepilone Compared With Mitoxantrone and Prednisone in Treating Patients With Refractory Metastatic Prostate Cancer (NCT00058084) | National Cancer Institute (NCI) | 2003-03-01 |
| Perifosine in Treating Patients With Recurrent Prostate Cancer (NCT00058214) | National Cancer Institute (NCI) | 2003-03-01 |
| Combination Chemotherapy and Rituximab in Treating Patients With HIV-Associated Stage I, Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma (NCT00049036) | National Cancer Institute (NCI) | 2003-03-01 |
| Acupuncture in Treating Mucositis-Related Pain Caused by Chemotherapy in Patients Undergoing Stem Cell Transplantation (NCT00060021) | National Cancer Institute (NCI) | 2003-03-01 |
| Oblimersen and Gemcitabine in Treating Patients With Advanced Solid Tumor or Lymphoma (NCT00060112) | National Cancer Institute (NCI) | 2003-03-01 |
| Bryostatin 1 Plus Vincristine in Treating Patients With Progressive or Relapsed Non-Hodgkin's Lymphoma After Bone Marrow or Stem Cell Transplantation (NCT00058305) | National Cancer Institute (NCI) | 2003-03-01 |
| Bevacizumab to Treat Kaposi's Sarcoma in HIV-Positive and HIV-Negative Patients (NCT00055237) | National Cancer Institute (NCI) | 2003-02-26 |
| Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal Cancer (NCT00050752) | National Cancer Institute (NCI) | 2003-02-24 |
| High-Risk Breast Duct Epithelium (NCT00028340) | National Cancer Institute (NCI) | 2003-02-20 |
| Monoclonal Antibody Therapy and Interleukin-2 in Treating Patients With Metastatic Melanoma (NCT00058279) | National Cancer Institute (NCI) | 2003-02-01 |
| Bevacizumab in Treating Patients With Unresectable Nonmetastatic Liver Cancer (NCT00055692) | National Cancer Institute (NCI) | 2003-02-01 |
| Tipifarnib, Doxorubicin, and Cyclophosphamide in Treating Women With Locally Advanced Breast Cancer (NCT00049114) | National Cancer Institute (NCI) | 2003-02-01 |
| Imatinib Mesylate in Treating Patients With Recurrent Meningioma (NCT00045734) | National Cancer Institute (NCI) | 2003-02-01 |
| Ixabepilone in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma (NCT00058019) | National Cancer Institute (NCI) | 2003-02-01 |
| PS-341 Alone and PS-341 Plus EPOCH Chemotherapy to Treat Non-Hodgkin's Lymphoma (NCT00054665) | National Cancer Institute (NCI) | 2003-02-01 |
| Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer (NCT00041080) | National Cancer Institute (NCI) | 2003-02-01 |
| Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors (NCT00058253) | National Cancer Institute (NCI) | 2003-02-01 |
| Cause of Familial Testicular Cancer (NCT00034424) | National Cancer Institute (NCI) | 2003-01-13 |
| Study of Health Effects of Cosmetic Breast Augmentation (NCT00342953) | National Cancer Institute (NCI) | 2003-01-10 |
| Modified Stem Cell Transplant Procedure to Treat Patients With Blood and Immune System Cancers (NCT00051311) | National Cancer Institute (NCI) | 2003-01-03 |
| Combination Chemotherapy and Imatinib Mesylate in Treating Children With Relapsed Acute Lymphoblastic Leukemia (NCT00049569) | National Cancer Institute (NCI) | 2003-01-01 |
| Imatinib Mesylate and Decitabine in Treating Patients With Chronic Myelogenous Leukemia (NCT00054431) | National Cancer Institute (NCI) | 2003-01-01 |
| Oxaliplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Cervical Cancer (NCT00057863) | National Cancer Institute (NCI) | 2003-01-01 |
| Bevacizumab and PEG-Interferon Alfa-2b in Treating Patients With Metastatic or Unresectable Carcinoid Tumors (NCT00055809) | National Cancer Institute (NCI) | 2003-01-01 |
| Bortezomib in Treating Patients With Advanced Cancer and Kidney Dysfunction (NCT00054483) | National Cancer Institute (NCI) | 2003-01-01 |
| Vaccine Therapy and Interleukin-2 in Treating Patients With Metastatic Melanoma (NCT00054535) | National Cancer Institute (NCI) | 2003-01-01 |
| Oblimersen Sodium and Rituximab in Treating Patients With Recurrent B-cell Non-Hodgkin Lymphoma (NCT00054639) | National Cancer Institute (NCI) | 2003-01-01 |
| Debulking and Chemotherapy With or Without Intraperitoneal Chemotherapy to Treat Peritoneal Carcinomatosis (NCT00052962) | National Cancer Institute (NCI) | 2003-01-01 |
| Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors (NCT00039494) | National Cancer Institute (NCI) | 2002-12-01 |
| Pirfenidone in Treating Young Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas (NCT00053937) | National Cancer Institute (NCI) | 2002-12-01 |
| Pyrazoloacridine and Stem Cell or Bone Marrow Transplantation in Treating Young Patients With High-Risk Neuroblastoma (NCT00053950) | National Cancer Institute (NCI) | 2002-12-01 |
| Erlotinib Hydrochloride and Bevacizumab in Treating Patients With Stage IV Breast Cancer (NCT00054132) | National Cancer Institute (NCI) | 2002-12-01 |
| Bortezomib With or Without Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer (NCT00052689) | National Cancer Institute (NCI) | 2002-12-01 |
| Suramin and Paclitaxel in Treating Women With Stage IIIB-IV Breast Cancer (NCT00054028) | National Cancer Institute (NCI) | 2002-12-01 |
| SGN-00101 in Preventing Anal Cancer in Patients With HIV Who Have Anal Neoplasia (NCT00052897) | National Cancer Institute (NCI) | 2002-12-01 |
| Tipifarnib Plus Tamoxifen in Treating Women With Metastatic Breast Cancer (NCT00052728) | National Cancer Institute (NCI) | 2002-12-01 |
| Interleukin-12 and Interleukin-2 in Treating Patients With Refractory or Recurrent Neuroblastoma (NCT00054405) | National Cancer Institute (NCI) | 2002-12-01 |
| Decitabine in Treating Children With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia (NCT00042796) | National Cancer Institute (NCI) | 2002-12-01 |
| Preliminary Study of Endometrial Hyperplasia Groundwork for a Study to Define Precursors of Endometrial Cancer (NCT00339651) | National Cancer Institute (NCI) | 2002-11-25 |
| Phase I Study of HeFi-1 to Treat Cancers With CD30 Protein (NCT00048880) | National Cancer Institute (NCI) | 2002-11-05 |
| Vaccine and Chemotherapy for Previously Untreated Metastatic Breast Cancer (NCT00048893) | National Cancer Institute (NCI) | 2002-11-01 |
| Oblimersen Plus Combination Chemotherapy and Dexrazoxane in Treating Children and Adolescents With Relapsed or Refractory Solid Tumors (NCT00039481) | National Cancer Institute (NCI) | 2002-11-01 |
| Oblimersen and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia (NCT00049192) | National Cancer Institute (NCI) | 2002-11-01 |
| Ixabepilone in Treating Patients With Metastatic or Recurrent Squamous Cell Cancer of the Head and Neck (NCT00033618) | National Cancer Institute (NCI) | 2002-11-01 |
| Depsipeptide to Treat Thyroid and Other Advanced Cancers (NCT00048334) | National Cancer Institute (NCI) | 2002-10-26 |
| Erlotinib Plus Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Head and Neck Cancer (NCT00055770) | National Cancer Institute (NCI) | 2002-10-01 |
| Booster Vaccination in Preventing Disease Recurrence in Previously Vaccinated Patients With Melanoma That Has Been Removed By Surgery (NCT01989559) | National Cancer Institute (NCI) | 2002-10-01 |
| Arsenic Trioxide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma (NCT00045565) | National Cancer Institute (NCI) | 2002-10-01 |
| A Phase I/II Trial of BMS-247550 for Treatment of Patients With Recurrent High-Grade Gliomas (NCT00045708) | National Cancer Institute (NCI) | 2002-10-01 |
| Brachytherapy in Treating Patients With Recurrent Malignant Glioma (NCT00045474) | National Cancer Institute (NCI) | 2002-10-01 |
| Phase II Trial of Peginterferon Alpha-2b and Thalidomide in Adults With Recurrent Gliomas (NCT00047879) | National Cancer Institute (NCI) | 2002-10-01 |